|
Volumn 114, Issue 6, 2004, Pages 1670-1671
|
Early closure of the Watterberg trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
STEROID;
HYDROCORTISONE;
CLINICAL TRIAL;
DIGESTIVE SYSTEM PERFORATION;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LOW DRUG DOSE;
LUNG DYSPLASIA;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ADRENAL INSUFFICIENCY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CHEMICALLY INDUCED DISORDER;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
ETHICS;
INTESTINE PERFORATION;
NEWBORN;
PREMATURITY;
RANDOMIZED CONTROLLED TRIAL;
STOMACH;
TREATMENT FAILURE;
VERY LOW BIRTH WEIGHT;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ADRENAL INSUFFICIENCY;
BRONCHOPULMONARY DYSPLASIA;
HUMANS;
HYDROCORTISONE;
INFANT, NEWBORN;
INFANT, PREMATURE;
INFANT, PREMATURE, DISEASES;
INFANT, VERY LOW BIRTH WEIGHT;
INTESTINAL PERFORATION;
RANDOMIZED CONTROLLED TRIALS;
STOMACH;
TREATMENT FAILURE;
|
EID: 16644364978
PISSN: 00314005
EISSN: 00314005
Source Type: Journal
DOI: 10.1542/peds.2004-2178 Document Type: Note |
Times cited : (11)
|
References (4)
|